Biochemical and biophysical characterization of lysozyme modified by PEGylation

被引:59
作者
Freitas, Debora da Silva [1 ]
Abrahao-Neto, Jose [1 ]
机构
[1] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pharmaceut Technol & Biochem, BR-05508000 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Antimicrobial activity; Lysozyme; PEGylation; Physical-chemical stability; Proteolysis resistance; SITE-SPECIFIC PEGYLATION; POLY(ETHYLENE GLYCOL); POLYETHYLENE-GLYCOL; REVERSIBLE PEGYLATION; CHEMICAL-MODIFICATION; PROTEIN PEGYLATION; ESCHERICHIA-COLI; ATTACHMENT; PEPTIDE; PROTECTION;
D O I
10.1016/j.ijpharm.2010.03.036
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PEGylation is a strategy that has been used to improve the biochemical properties of proteins and their physical and thermal stabilities. In this study, hen egg-white lysozyme (EC 3.2.1.17; LZ) was modified with methoxypolyethylene glycol-p-nitrophenyl carbonate (mPEG-pNP, MW 5000). This PEGylation of LZ produced conjugates that retained full enzyme activity with glycol chitosan, independent of degree of enzyme modification; its biological activity with the substrate Micrococcus lysodeikticus was altered according to its degree of modification. The conjugate obtained with a low degree of mPEG-pNP/NH2 modification was studied by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF), demonstrating a spectral peak at m/z 19,988 Da with 77% of its original enzymatic activity. Spectroscopic studies of Fourier transform infrared (FIR) and circular dichroism (CD) did not show any relevant differences in protein structure between the native and conjugate LZ. Studies of the effects of pH and temperature on PEGylated LZ indicated that the conjugate was active over a broad pH range, stable at 50 degrees C, and demonstrated resistance to proteolytic degradation. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:111 / 117
页数:7
相关论文
共 48 条
[1]  
ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582
[2]   Polyethylene glycol-conjugated pharmaceutical proteins [J].
Bailon, P ;
Berthold, W .
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (08) :352-356
[3]   Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge [J].
Balan, Sibu ;
Choi, Ji-won ;
Godwin, Antony ;
Teo, Ian ;
Laborde, Carlos M. ;
Heidelberger, Sibylle ;
Zloh, Mire ;
Shaunak, Sunil ;
Brocchini, Steve .
BIOCONJUGATE CHEMISTRY, 2007, 18 (01) :61-76
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   ACTIVE-SITE PROTECTION OF PROTEOLYTIC-ENZYMES BY POLY(ETHYLENE GLYCOL) SURFACE MODIFICATION [J].
CALICETI, P ;
SCHIAVON, O ;
SARTORE, L ;
MONFARDINI, C ;
VERONESE, FM .
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 1993, 8 (01) :41-50
[6]   Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates [J].
Caliceti, P ;
Veronese, FM .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (10) :1261-1277
[7]  
Caliceti P, 1990, J Mol Recognit, V3, P89, DOI 10.1002/jmr.300030206
[8]   PRESERVATION OF THROMBOLYTIC ACTIVITY OF UROKINASE MODIFIED WITH MONOMETHOXYPOLY(ETHYLENE GLYCOL) [J].
CALICETI, P ;
MORPURGO, M ;
SCHIAVON, O ;
MONFARDINI, C ;
VERONESE, FM .
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 1994, 9 (03) :252-266
[9]   C-terminal site-specific PEGylation of a truncated thrombomodulin mutant with retention of full bioactivity [J].
Cazalis, CS ;
Haller, CA ;
Sease-Cargo, L ;
Chaikof, EL .
BIOCONJUGATE CHEMISTRY, 2004, 15 (05) :1005-1009
[10]   ENZYMATIC-ACTIVITY OF CHYMOTRYPSIN AND ITS POLY(ETHYLENE GLYCOL) CONJUGATES TOWARD LOW AND HIGH-MOLECULAR-WEIGHT SUBSTRATES [J].
CHIU, HC ;
ZALIPSKY, S ;
KOPECKOVA, P ;
KOPECEK, J .
BIOCONJUGATE CHEMISTRY, 1993, 4 (04) :290-295